targeted therapy

Zhang S, Guclu SB, Lipsyc-Sharf M, Kapoor NS. Pregnancy and breast cancer in young women: current updates and future directions. Ther Adv Med Oncol. 2025[...]

By afschroeder • September 9, 2025

Ringel MD, Sosa JA, Baloch Z, Bischoff L, Bloom G, Brent GA, Brock PL, Chou R, Flavell RR, Goldner W, Grubbs EG, Haymart M, Larson[...]

By afschroeder • August 23, 2025

Konecny GE, Davidson TM, Lebreton CL, Marsh LA, Chetram DK, Atkinson HJ, Larson MC, Oberg AL, Abdelaal N, Silverstein J, Jatoi A, Washburn A, Burton[...]

By afschroeder • August 22, 2025

Smyth EC, Kim KM, Rha SY, Wainberg ZA, Honeycutt H, Sommermann E, Ochiai A. FGFR2b protein overexpression: An emerging biomarker in gastric and gastroesophageal junction[...]

By afschroeder • July 20, 2025

Chen H, Evans L, Schaaff C, Labib M, Oh E, Ashendouek M, Sajed D, Ho WC, Wong DJ, Martin EJ, St John M. Multidisciplinary Care[...]

By sjmartinez • May 10, 2025

Truong A, Liu J, Ni C, Yashar S. Chilblain lupus erythematosus associated with erdafitinib therapy in a patient with metastatic bladder cancer. JAAD Case Rep.[...]

By sjmartinez • December 10, 2024

Chow F, Lamoureux F, Moriceau G. Editorial: Developing next-generation therapeutics to defeat mutation-driven cancer. Front Immunol. 2024 Sep 26;15:1487952. doi: 10.3389/fimmu.2024.1487952. PMID: 39391312; PMCID: PMC11464455.

By sjmartinez • October 11, 2024

Evans LK, Chen H, Taki Labib M, Cronkite DA, Yu AC, Ashendouek M, Elashoff D, Chai-Ho W, Wong DJ, St John M. Improved Survival of[...]

By sjmartinez • August 21, 2024

Cohen R, Raeisi M, Chibaudel B, Shi Q, Yoshino T, Zalcberg JR, Adams R, Cremolini C, Van Cutsem E, Heinemann V, Tabernero J, Punt CJA,[...]

By sjmartinez • June 20, 2024

Nassar AH, Kim SY, Aredo JV, Feng J, Shepherd F, Xu C, Kaldas D, Gray JE, Dilling TJ, Neal JW, Wakelee HA, Liu Y, Lin[...]

By sjmartinez • June 9, 2024